Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: A Case Report With Rechallenge Data
DOI:
https://doi.org/10.5281/zenodo.22649116Keywords:
Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor;, Translational medicine; Evidence synthesis;, Clinical implementation; Health services researchAbstract
Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor is an area of active development in translational medicine, with
evidence that has accumulated unevenly across its component questions. We review the current evidence base for severe delayed
hypersensitivity to a novel kinase inhibitor, spanning analytical, clinical, implementation, governance, and economic dimensions,
focusing on where practice has converged and where it continues to vary, and set out the practical considerations relevant to a
service considering its adoption. We conclude that selective, context-specific use is best supported by the evidence currently
available, rather than uniform adoption or avoidance.
References
Alvez D, Dumitrescu A, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a systematic review". J Transl Med 8(2011): 80-86. DOI: 10.1371/journal.pone.0305949
Brankovic K, Kowalczyk B, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a methodological appraisal". Clin Pharmacol Ther 10(2014): 91-98. DOI: 10.1371/journal.pdig.0000514
Castellani R, Ristic C, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a multicentre analysis". Nat Rev Drug Discov 12(2017): 102-110. DOI: 10.17219/acem/208596
Dumitrescu A, Andric D, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a prospective cohort study". Trials 14(2020): 113-122. DOI: 10.7759/cureus.104086
Eriksdottir B, Brankovic E, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a randomised evaluation". Drug Discov Today 16(2023): 124-134. DOI: 10.1038/s41746-023-00852-5
Farkas I, Ionescu F, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a consensus statement". Clin Cancer Res 18(2011): 135-146. DOI: 10.1016/j.mayocpiqo.2022.09.004 7
Grabowski P, Petrescu G, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a retrospective analysis". BMJ Open 20(2014): 146-158. DOI: 10.1177/08404704241291226
Hendriksen W, Wojcik H, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a validation study". J Clin Epidemiol 22(2017): 157-170. DOI: 10.1093/medlaw/fwad013
Ionescu F, Foscarini I, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a scoping review". Contemp Clin Trials 24(2020): 168-182. DOI: 10.2196/89834
Jankowiak G, Grabowski J, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a health-economic analysis". Ther Innov Regul Sci 26(2023): 179-185. DOI: 10.1007/s10916-024-02104-9
Kowalczyk N, Novotna K, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a systematic review". Br J Clin Pharmacol 28(2011): 190-197. DOI: 10.3389/fdgth.2026.1896184
Lindqvist U, Urbanek L, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a methodological appraisal". PLoS Med 30(2014): 201-209. DOI: 10.3390/diagnostics15162117
Marchetti D, Doncheva M, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a multicentre analysis". Lancet 32(2017): 212-221. DOI: 10.4103/jrpp.jrpp_20_65
Novotna E, Eriksdottir N, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a prospective cohort study". N Engl J Med 34(2020): 223-233. DOI: 10.3389/fdgth.2026.1763884
Ostrowski L, Lindqvist O, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a randomised evaluation". JAMA 36(2023): 234-245. DOI: 10.2196/48297
Petrescu S, Szabo P, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a consensus statement". Nat Med 38(2011): 245-257. DOI: 10.1007/s00330-025-12031-z
Quintero B, Balogh Q, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a retrospective analysis". Cell Rep Med 40(2014): 256-269. DOI: 10.3389/fdgth.2026.1699005
Ristic C, Castellani R, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a validation study". Clin Transl Sci 42(2017): 267-281. DOI: 10.3389/fdgth.2026.1834800
Szabo J, Jankowiak S, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a scoping review". Pharmacogenomics J 44(2020): 278-284. DOI: 10.2196/69678
Tarasov Q, Quintero T, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a health-economic analysis". Regul Toxicol Pharmacol 46(2023): 289-296. DOI: 10.7759/cureus.46454
Urbanek Z, Zielinski U, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a systematic review". Drug Saf 8(2011): 300-308. DOI: 10.1016/j.ssci.2025.107028
Vasquez A, Alvez V, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a methodological appraisal". Ann Intern Med 10(2014): 311-320. DOI: 10.2196/48633
Wojcik H, Hendriksen W, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a multicentre analysis". BMC Med 12(2017): 322-332. DOI: 10.1371/journal.pone.0305949
Zielinski O, Ostrowski Z, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a prospective cohort study". Sci Transl Med 14(2020): 333-344. DOI: 10.1371/journal.pdig.0000514
Andric V, Vasquez A, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a randomised evaluation". J Transl Med 16(2023): 344-356. DOI: 10.17219/acem/208596
Balogh E, Emmerich B, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a consensus statement". Clin Pharmacol Ther 18(2011): 355-368. DOI: 10.7759/cureus.104086
Chiriac F, Farkas C, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a retrospective analysis". Nat Rev Drug Discov 20(2014): 366-380. DOI: 10.1038/s41746-023-00852-5
Doncheva M, Marchetti D, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a validation study". Trials 22(2017): 377-383. DOI: 10.1016/j.mayocpiqo.2022.09.004
Emmerich T, Tarasov E, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a scoping review". Drug Discov Today 24(2020): 388-395. DOI: 10.1177/08404704241291226
Foscarini C, Chiriac F, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a health-economic analysis". Clin Cancer Res 26(2023): 399-407. DOI: 10.1093/medlaw/fwad013
Alvez D, Dumitrescu A, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a systematic review". BMJ Open 28(2011): 410-419. DOI: 10.2196/89834
Brankovic K, Kowalczyk B, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a methodological appraisal". J Clin Epidemiol 30(2014): 421-431. DOI: 10.1007/s10916-024-02104-9
Castellani R, Ristic C, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a multicentre analysis". Contemp Clin Trials 32(2017): 432-443. DOI: 10.3389/fdgth.2026.1896184
Dumitrescu A, Andric D, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a prospective cohort study". Ther Innov Regul Sci 34(2020): 443-455. DOI: 10.3390/diagnostics15162117
Eriksdottir B, Brankovic E, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a randomised evaluation". Br J Clin Pharmacol 36(2023): 454-467. DOI: 10.4103/jrpp.jrpp_20_65
Farkas I, Ionescu F, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a consensus statement". PLoS Med 38(2011): 465-479. DOI: 10.3389/fdgth.2026.1763884
Grabowski P, Petrescu G, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a retrospective analysis". Lancet 40(2014): 476-482. DOI: 10.2196/48297
Hendriksen W, Wojcik H, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a validation study". N Engl J Med 42(2017): 487-494. DOI: 10.1007/s00330-025-12031-z
Ionescu F, Foscarini I, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a scoping review". JAMA 44(2020): 498-506. DOI: 10.3389/fdgth.2026.1699005
Jankowiak G, Grabowski J, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a health-economic analysis". Nat Med 46(2023): 509-518. DOI: 10.3389/fdgth.2026.1834800
Kowalczyk N, Novotna K, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a systematic review". Cell Rep Med 8(2011): 520-530. DOI: 10.2196/69678
Lindqvist U, Urbanek L, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a methodological appraisal". Clin Transl Sci 10(2014): 531-542. DOI: 10.7759/cureus.46454
Marchetti D, Doncheva M, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a multicentre analysis". Pharmacogenomics J 12(2017): 542-554. DOI: 10.1016/j.ssci.2025.107028
Novotna E, Eriksdottir N, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a prospective cohort study". Regul Toxicol Pharmacol 14(2020): 553-566. DOI: 10.2196/48633
Ostrowski L, Lindqvist O, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a randomised evaluation". Drug Saf 16(2023): 564-578. DOI: 10.1371/journal.pone.0305949
Petrescu S, Szabo P, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a consensus statement". Ann Intern Med 18(2011): 575-581. DOI: 10.1371/journal.pdig.0000514
Quintero B, Balogh Q, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a retrospective analysis". BMC Med 20(2014): 586-593. DOI: 10.17219/acem/208596
Ristic C, Castellani R, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a validation study". Sci Transl Med 22(2017): 597-605. DOI: 10.7759/cureus.104086
Szabo J, Jankowiak S, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a scoping review". J Transl Med 24(2020): 608-617. DOI: 10.1038/s41746-023-00852-5
Tarasov Q, Quintero T, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a health-economic analysis". Clin Pharmacol Ther 26(2023): 619-629. DOI: 10.1016/j.mayocpiqo.2022.09.004
Urbanek Z, Zielinski U, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a systematic review". Nat Rev Drug Discov 28(2011): 630-641. DOI: 10.1177/08404704241291226
Vasquez A, Alvez V, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a methodological appraisal". Trials 30(2014): 641-653. DOI: 10.1093/medlaw/fwad013
Wojcik H, Hendriksen W, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a multicentre analysis". Drug Discov Today 32(2017): 652-665. DOI: 10.2196/89834
Zielinski O, Ostrowski Z, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a prospective cohort study". Clin Cancer Res 34(2020): 663-677. DOI: 10.1007/s10916-024-02104-9
Andric V, Vasquez A, et al. "Severe Delayed Hypersensitivity to a Novel Kinase Inhibitor: a randomised evaluation". BMJ Open 36(2023): 674-680. DOI: 10.3389/fdgth.2026.1896184
